Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.

PURPOSE:To evaluate changes in the concentrations of placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A) in aqueous humor of patients with neovascular glaucoma (NVG) before and after an intravitreal injection of ranibizumab (IVR) and to determine the underlying correlati...

Full description

Bibliographic Details
Main Authors: Minwen Zhou, Jiawei Wang, Wei Wang, Wenbin Huang, Xiaoyan Ding, Xiulan Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4718677?pdf=render
_version_ 1828339827403128832
author Minwen Zhou
Jiawei Wang
Wei Wang
Wenbin Huang
Xiaoyan Ding
Xiulan Zhang
author_facet Minwen Zhou
Jiawei Wang
Wei Wang
Wenbin Huang
Xiaoyan Ding
Xiulan Zhang
author_sort Minwen Zhou
collection DOAJ
description PURPOSE:To evaluate changes in the concentrations of placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A) in aqueous humor of patients with neovascular glaucoma (NVG) before and after an intravitreal injection of ranibizumab (IVR) and to determine the underlying correlation between the levels. METHODS:The prospective interventional comparative study involved 20 eyes of 20 patients with surgery-required advanced NVG and 20 control subjects from January 2013 to November 2013. The NVG eyes received the IVR treatment before glaucoma surgery. Aqueous humor was collected at the time of the IVR injection (pre- IVR) and at the time of antiglaucomatous surgery (post-IVR). Aqueous humor was also collected at the time of cataract surgery in normal control. Aqueous humor and plasma VEGF-A and PlGF levels were measured with an enzyme-linked immunosorbent assay methods, respectively. RESULTS:The mean aqueous humor PlGF and VEGF-A concentrations in the pre-IVR eyes were significantly higher than in those of the control subjects (p<0.001), whereas the plasma levels showed no significant difference. There was a statistically significant correlation between the aqueous humor PlGF and the VEGF-A concentration (r = 0.612, p = 0.003). The mean aqueous humor PlGF in the post-IVR eyes dramatically decreased from 1078.36 ± 755.83 to 177.64 ± 151.73 pg/mL (p<0.001). The VEGF-A level showed a similar trend from 3697.64 ± 2104.47 pg/mL to 183.54 ± 130.35 pg/mL (p<0.001). CONCLUSIONS:Aqueous humor concentrations of VEGF-A and PlGF were significantly elevated in the eyes with NVG, and there was a positive correlation between the levels. After an IVR treatment, VEGF-A and PlGF were significantly decreased in NVG eyes.
first_indexed 2024-04-13T22:48:38Z
format Article
id doaj.art-bee3e9f7ace04d218ceb4918bb25fbd3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T22:48:38Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-bee3e9f7ace04d218ceb4918bb25fbd32022-12-22T02:26:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01111e014699310.1371/journal.pone.0146993Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.Minwen ZhouJiawei WangWei WangWenbin HuangXiaoyan DingXiulan ZhangPURPOSE:To evaluate changes in the concentrations of placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A) in aqueous humor of patients with neovascular glaucoma (NVG) before and after an intravitreal injection of ranibizumab (IVR) and to determine the underlying correlation between the levels. METHODS:The prospective interventional comparative study involved 20 eyes of 20 patients with surgery-required advanced NVG and 20 control subjects from January 2013 to November 2013. The NVG eyes received the IVR treatment before glaucoma surgery. Aqueous humor was collected at the time of the IVR injection (pre- IVR) and at the time of antiglaucomatous surgery (post-IVR). Aqueous humor was also collected at the time of cataract surgery in normal control. Aqueous humor and plasma VEGF-A and PlGF levels were measured with an enzyme-linked immunosorbent assay methods, respectively. RESULTS:The mean aqueous humor PlGF and VEGF-A concentrations in the pre-IVR eyes were significantly higher than in those of the control subjects (p<0.001), whereas the plasma levels showed no significant difference. There was a statistically significant correlation between the aqueous humor PlGF and the VEGF-A concentration (r = 0.612, p = 0.003). The mean aqueous humor PlGF in the post-IVR eyes dramatically decreased from 1078.36 ± 755.83 to 177.64 ± 151.73 pg/mL (p<0.001). The VEGF-A level showed a similar trend from 3697.64 ± 2104.47 pg/mL to 183.54 ± 130.35 pg/mL (p<0.001). CONCLUSIONS:Aqueous humor concentrations of VEGF-A and PlGF were significantly elevated in the eyes with NVG, and there was a positive correlation between the levels. After an IVR treatment, VEGF-A and PlGF were significantly decreased in NVG eyes.http://europepmc.org/articles/PMC4718677?pdf=render
spellingShingle Minwen Zhou
Jiawei Wang
Wei Wang
Wenbin Huang
Xiaoyan Ding
Xiulan Zhang
Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
PLoS ONE
title Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
title_full Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
title_fullStr Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
title_full_unstemmed Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
title_short Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
title_sort placenta growth factor in eyes with neovascular glaucoma is decreased after intravitreal ranibizumab injection
url http://europepmc.org/articles/PMC4718677?pdf=render
work_keys_str_mv AT minwenzhou placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection
AT jiaweiwang placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection
AT weiwang placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection
AT wenbinhuang placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection
AT xiaoyanding placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection
AT xiulanzhang placentagrowthfactorineyeswithneovascularglaucomaisdecreasedafterintravitrealranibizumabinjection